https://onlinelibrary.wiley.com/doi/epdf/10.1111/acel.70597
chatGPT(5.5paid):
Summary
This is a 2026 review article on how single-cell RNA sequencing has reshaped understanding of arterial aging. Its central argument is that arterial aging is not just a uniform deterioration of the vessel wall, but a shift in the composition, state, and communication of multiple vascular cell populations: endothelial cells, smooth muscle cells, fibroblasts, and immune cells.
The review organizes arterial aging around four recurring programs:
1. Cellular senescence
The authors argue that senescence in arteries is not a simple binary state marked by p16 or p21. Single-cell studies show it as a continuum, with intermediate transcriptional states and cell-type-specific signatures. Senescence overlaps with inflammation, ECM remodeling, and secretory phenotypes.
2. Extracellular matrix remodeling
Aging arteries stiffen partly because of changes in collagen, elastin, crosslinking, and mechanosensing. The review emphasizes that ECM remodeling is not merely “more matrix”; it is produced by distinct cell states, especially fibroblast and smooth muscle cell subsets. Fibroblast populations such as CD55+, CXCL14+, and LOX+ subsets are discussed as contributors to collagen accumulation, adventitial thickening, and crosslinking.
3. Inflammaging
Inflammation in aging arteries is presented as arising from specific cell subsets, not a uniform inflammatory increase across all cells. Macrophages, T-cell states, and age-associated B cells are highlighted as drivers of local inflammatory signalling.
4. Altered cell–cell communication
The paper places considerable weight on changing communication networks between ECs, SMCs, fibroblasts, and immune cells. Aging is framed as a shift away from vascular homeostatic signalling and toward inflammatory, remodeling, calcific, and immune-vascular interactions.
By cell type:
Endothelial cells shift from vasoprotective, nitric-oxide-associated states toward senescent, inflammatory, pro-fibrotic, and matrix-remodeling states. The paper highlights candidates such as BACH1, FOXO3A, YAP/TAZ, TEAD1, and EndoMT-related programs.
Smooth muscle cells shift from contractile states toward synthetic, stressed, inflammatory, apoptotic, osteogenic, or senescence-associated states. SPP1/osteopontin, FN1, and mechanosensing changes such as Piezo1 are discussed as important.
Fibroblasts are presented as under-studied but central to adventitial collagen accumulation, stiffening, and inflammatory signalling. The review stresses their plasticity, possible progenitor-like states, and myofibroblast transition.
Immune cells show age-associated functional reprogramming: pro-inflammatory macrophages, GZMK+ or exhaustion-like T-cell states, and antigen-presenting age-associated B cells.
The paper ends by arguing that the field needs better cross-species integration, spatial transcriptomics, single-cell epigenomics, sex-stratified studies, and functional validation of the inferred cell states.
Novelty
The paper’s novelty is mainly synthetic and conceptual, rather than experimental. It does not generate new datasets, but it tries to impose a coherent framework on a fragmented literature.
The main novel contributions are:
A unified cell-state framework for arterial aging.
The authors attempt to standardize the way arterial aging cell states are discussed, grouping them by function rather than relying on inconsistent cluster names from individual single-cell studies.
Integration across cell types.
Rather than treating endothelial aging, SMC aging, fibroblast aging, and immune aging separately, the review frames arterial aging as a multicellular tissue-level process.
Emphasis on cell–cell communication.
The review usefully moves beyond “which genes change in which cells” and argues that aging alters ligand–receptor signalling across the arterial wall.
Cross-species perspective.
It compares mouse, rat, nonhuman primate, and human evidence and stresses that some aging programs are conserved, while others are species-, sex-, vascular-bed-, or disease-context-specific.
Recognition that senescence is heterogeneous.
The paper pushes against the oversimplified use of canonical senescence markers and instead presents vascular senescence as a continuum embedded within broader functional programs.
Critique
The paper is useful, but its limitations are substantial.
First, it is a review, not a primary experimental paper. The conclusions depend on how well the authors select, interpret, and harmonize existing studies. It does not itself validate any of the proposed cell states.
Second, many of the underlying single-cell studies infer function from transcriptomic signatures, pathway enrichment, or ligand–receptor algorithms. These approaches are informative but indirect. A cell expressing an ECM gene set is not necessarily proven to be causally responsible for arterial stiffness; a predicted ligand–receptor interaction is not proof of functional signalling.
Third, the review repeatedly identifies candidate drivers — such as BACH1, FOXO3A, YAP/TAZ, SPP1, Piezo1, LOX+ fibroblasts, and immune subsets — but causal hierarchy remains unclear. Are these drivers of arterial aging, consequences of aging, compensatory responses, or disease-associated bystanders?
Fourth, disease and aging are partly conflated. Several datasets come from atherosclerosis, hypertension, hypercholesterolemia, or experimental injury contexts. These are relevant to vascular aging, but they are not identical to uncomplicated chronological aging. The paper acknowledges this problem, but the framework still leans heavily on mixed aging–disease evidence.
Fifth, spatial context remains weak. The arterial wall is highly organized: intima, media, adventitia, vasa vasorum, plaque shoulder, calcified regions, and immune niches matter. scRNA-seq loses much of this architecture, so conclusions about communication across the wall need spatial validation.
Sixth, fibroblasts are treated as highly important, but the evidence base is thinner than for endothelial cells and smooth muscle cells. The review is right to highlight fibroblasts, but many claims about their causal role in arterial stiffening still need lineage tracing, depletion, or targeted perturbation studies.
Seventh, sex differences are underdeveloped. The review notes that many studies are male-only or insufficiently sex-stratified. Given the differences in vascular aging, menopause, immune aging, and cardiovascular risk between sexes, this is a major gap.
Finally, the paper could have been sharper in distinguishing cell abundance changes from within-cell transcriptional changes. Single-cell studies often blur whether aging increases the number of a cell state, changes the expression profile of an existing state, or both.
Overall assessment
This is a strong and timely review that organizes the arterial-aging single-cell literature into a useful multicellular framework. Its most valuable contribution is the idea that arterial aging is driven by interacting, heterogeneous cell states rather than uniform deterioration of the vessel wall.
Its main weakness is that much of the field remains descriptive and correlative. The next step is not merely better annotation of cell clusters, but causal testing: perturbing candidate cell states, signalling pathways, and ECM-remodeling programs in spatially resolved, sex-aware, human-relevant models.